Q2 2018 Holdings
Filed 2018-08-09 | 25 holdings | $157.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | Common | 09062X103 | $81.1M | 279,564 | 51.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $42.6M | 1,591,743 | 27.1% |
| Agios Pharmaceuticals Inc(AGIO) | Common | 00847X104 | $32.8M | 390,000 | 20.9% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $254.3K | 11,213,879 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $194.2K | 4,717,010 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $173.9K | 11,924,614 | 0.1% |
| Evofem Biosciences Inc(NEOTEUR) | Common | 30048L104 | $26.0K | 9,593,197 | 0.0% |
| Nucana PLC | SPON ADR | 67022C106 | $8.0K | 420,000 | 0.0% |
| Altria Group Inc(MO) | Common | 02209S103 | $6.7K | 118,000 | 0.0% |
| Nightstar Therapeutics PLC | ADR | 65413A101 | $5.0K | 314,000 | 0.0% |